Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1014 of 5804
-
New microscope could speed up cervical cancer diagnosis in minutes
Diagnosis Not yet recruitingAll patients will be enrolled in Mozambique and Brazil. They will provide informed consent to use their cervical biopsy and/or LEEP specimens for imaging with DeepDOF prior to sending for standard of care processing and interpretation.
Phase: NA • Sponsor: M.D. Anderson Cancer Center • Aim: Diagnosis
Last updated Jun 27, 2026 11:00 UTC
-
Magic mushroom compound tested for back pain relief in new yale study
Symptom relief Not yet recruitingThe purpose of this research study is to investigate whether a single administration of psilocybin can improve interoceptive awareness (awareness of bodily sensations) in individuals with chronic low back pain undergoing physical therapy, and whether these improvements are linked…
Phase: PHASE2 • Sponsor: Yale University • Aim: Symptom relief
Last updated Jul 18, 2026 00:00 UTC
-
New implant aims to silence snoring and save lives
Disease control Recruiting nowThe objective of the BREATHE study is to demonstrate the continued safety and effectiveness of the Genio® System in treating subjects diagnosed with moderate to severe obstructive sleep apnea (OSA) who are intolerant to or failed/refused PAP treatments.
Sponsor: Nyxoah Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Can a phone app help beat opioid addiction? new trial aims to find out
Disease control Not yet recruitingThis trial will assess effects of enrollment in a comprehensive telehealth platform, RecoveryPad (RP), in adults with moderate or severe opioid use disorder.
Phase: NA • Sponsor: Yale University • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
New hope for rare bleeding disorder: coagadex trial targets AL amyloidosis
Disease control TerminatedThe purpose of this study is to evaluate the efficacy and safety of Coagadex in treating active bleeds and to manage peri-operative bleeding in participants with acquired factor X deficiency associated with AL amyloidosis.
Phase: PHASE3 • Sponsor: Kedrion S.p.A. • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
New balloon could open blocked leg arteries without surgery
Disease control Not yet recruitingThis clinical trial will evaluate the study device, Passeo®-18 Lux® paclitaxel-releasing percutaneous transluminal angioplasty (PTA) balloon catheter for the treatment of new or recurring cholesterol-related blockages in the arteries of the lower leg. The device that is used in …
Phase: NA • Sponsor: KANDO Research • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
New hope for painful skin condition: drug trial launches
Disease control Not yet recruitingLichen planus (LP) is a common immune-mediated skin disease with a prevalence of 1-2% in the general population. It can present with a broad spectrum of clinical manifestations affecting primarily the skin (cutaneous LP \[CLP\]), the mucosae (mucosal LP \[MLP\]), hair follicles (…
Phase: PHASE2 • Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Placental membrane may speed burn healing in new clinical trial
Disease control Not yet recruitingThis study will evaluate the efficacy of a dehydrated human placental tissue product, commercially labeled as AmCoreMatrix Burn ™ versus SOC in the closure of partial thickness burns. Human Cellular and Tissue based Products (HCT/Ps), specifically Dehydrated Human Amnion - Interm…
Phase: PHASE4 • Sponsor: Cellution Biologics • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Could a diabetes drug boost psoriasis treatment in overweight patients?
Disease control Not yet recruitingThis is a randomized, double-blind, placebo-controlled, multicenter clinical trial conducted in China. The study aims to evaluate the efficacy and safety of metformin combined with secukinumab in the treatment of moderate-to-severe plaque psoriasis in overweight or obese Chinese …
Phase: PHASE4 • Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Massive chicago study aims to curb opioid deaths with smarter screening
Knowledge-focused Not yet recruitingThis study, called the Chicago Data-driven Opioid use disorder Screening, Engagement, Treatment and Planning (C-DOSETaP) System, tests a new system of clinical care for patients with opioid use disorder (OUD) across a large health system. The main questions this study aims to an…
Phase: NA • Sponsor: University of Illinois at Chicago • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:01 UTC
-
New scan could sharpen breast cancer staging
Diagnosis Not yet recruitingThis study aims to evaluate the clinical utility of \[68Ga\]Ga-FAP-2268 PET/CT for disease staging and assessment in patients with high-risk primary breast cancer. By targeting fibroblast activation protein (FAP), this novel imaging approach may offer improved tumor visualization…
Phase: PHASE2 • Sponsor: Odense University Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 12:06 UTC
-
New scan could clarify prostate cancer return when standard test fails
Diagnosis Not yet recruitingThe impact of fluciclovine (18F) PET on the management of participants with prostate cancer following negative or equivocal PSMA PET Imaging at the time of biochemical recurrence
Phase: PHASE4 • Sponsor: Blue Earth Diagnostics • Aim: Diagnosis
Last updated Jun 27, 2026 13:00 UTC
-
New drug targets Hard-to-Treat cancers with missing gene
Disease control Not yet recruitingThis is a phase I, open-label, first-in-human study of CS08399, comprising two phases: dose escalation (including single-dose and multiple-dose) and cohort expansion. The primary objectives of this study are to evaluate the safety, tolerability and pharmacokinetic (PK) characteri…
Phase: PHASE1 • Sponsor: Chipscreen Biosciences, Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
Five sessions to save lives: new therapy targets suicidal teens
Symptom relief Not yet recruitingThe goal of this clinical trial is to learn if the Ultra-Brief Interpersonal Psychotherapy for Adolescents with Suicidal Ideation (IPT-A-SCI) works to reduce suicidal thoughts and behaviors in children and adolescents. The study will also examine whether treatment effects continu…
Phase: NA • Sponsor: Tel Aviv University • Aim: Symptom relief
Last updated Jun 27, 2026 13:06 UTC
-
Major study to uncover cancer Treatment's hidden toll on fertility
Knowledge-focused Not yet recruitingIn the past two decades, the evidence-based knowledge on the prevalence and risk factors for gonads impairment, including infertility, following cancer and numerous cancer treatment regimen has significantly increased. However, data remains mostly insufficient for individualized …
Sponsor: Karolinska Institutet • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:01 UTC
-
Lab test aims to match brain tumor patients with targeted drugs
Knowledge-focused Recruiting nowPatients will receive in addition to standard histology analysis also the PDC- based drug screening.
Phase: NA • Sponsor: Medical University of Vienna • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:03 UTC
-
Pee power: simple urine test could revolutionize heart failure care
Disease control Not yet recruitingThe SURE-HF trial is a pragmatic, multicentre, randomized controlled study evaluating natriuresis-guided optimization of intravenous loop diuretic therapy in patients hospitalized with worsening heart failure (WHF). The study aims to determine whether serial urinary sodium assess…
Phase: NA • Sponsor: Nurgul Ablakimova • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
New hope for stomach cancer: drug cocktail targets tough cases
Disease control Not yet recruitingThe combination of immune checkpoint inhibitors and platinum containing dual drugs are more used as a first-line therapeutic approach for patients diagnosed with advanced gastric cancer for its superior efficacy. However, there are no standard recommendations for subsequent treat…
Phase: PHASE2 • Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Can 'Supercharged' donor cells beat viruses that drugs Can't?
Disease control Recruiting nowThe goal of this clinical trial is to learn whether giving patients special donor immune cells (called "CD45RA Depleted DLI") can help treat viral infections that have not improved with standard antiviral drugs. These infections occur after a stem cell transplant. The study will …
Phase: PHASE1, PHASE2 • Sponsor: Ruijin Hospital • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
Zapping stomach tumors with calcium: a new way to stop bleeding?
Disease control Not yet recruitingBrief Summary Background Gastric cancer (GC) remains a major global public health challenge, ranking as the fifth most common malignancy worldwide and the third leading cause of cancer-related mortality. In 2018, approximately 1 million new cases and 783,000 deaths were reported…
Phase: NA • Sponsor: Hospital del Rio Hortega • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC